Company profile: Graviton
1.1 - Company Overview
Company description
- Provider of novel therapeutics for autoimmune, cancer, certain genetic, fibrotic, and other serious diseases.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Graviton
YorkTest
HQ: United Kingdom
Website
- Description: Provider of food intolerance programs and diagnostic testing services, providing personalized information and support to help optimize health and wellbeing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full YorkTest company profile →
Natrogen Therapeutics
HQ: United States
Website
- Description: Provider of Natura-alpha, a small-molecule oral compound undergoing clinical trials for patients with ulcerative colitis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Natrogen Therapeutics company profile →
Electra Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage monoclonal antibody therapies targeting SIRP proteins for cancer and immunological diseases. Lead candidate ELA026 is in clinical development for sHLH and preclinical for other inflammatory diseases, designed to deplete myeloid and T cells driving hyperinflammation. Additional SIRP-directed antibodies aim to deplete specific immune or tumor cells.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Electra Therapeutics company profile →
Attralus
HQ: United States
Website
- Description: Provider of biopharmaceutical therapies and imaging agents targeting amyloid and misfolded protein aggregates, including AT-02, a humanized IgG1 antibody fused with a pan-amyloid peptide to stimulate immune removal; AT-01 PET/CT and AT-05 SPECT agents for detecting amyloid deposits; AT-06 preclinical CAR-monocyte therapy; and a neurodegeneration program targeting Aβ, Tau, and α-Synuclein.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Attralus company profile →
NodThera
HQ: United Kingdom
Website
- Description: Provider of NLRP3 inflammasome inhibitor therapeutics targeting inflammatory and neuroinflammatory diseases, including brain-penetrant candidates. Lead asset NT-0796 is in Phase Ib/IIa for Parkinson’s disease and cardiovascular risk in obese patients; NT-0249 is optimized for low-dose chronic inflammatory therapy, with additional CNS and peripheral candidates under development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full NodThera company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Graviton
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Graviton
2.2 - Growth funds investing in similar companies to Graviton
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Graviton
4.2 - Public trading comparable groups for Graviton
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →